Dear Customer, If you experience any text readability or display issues on our website, please update your web browser to the latest version
.
See More
Dear Customer, If you experience any text readability or display issues on our website, please update your web browser to the latest version
.
See MoreDear Customer, If you experience any text readability or display issues on our website, please update your web browser to the latest version
.
This page has been recently translated and is available in French now.
Looks like you're visiting us from {countryName}.
Would you like to stay on the current location site or be switched to your location?
Identification of activated B lymphocytes using Mouse B Lymphocyte Activation Antibody Cocktail, with Isotype Control. BALB/c splenocytes were activated by culture for 48 hours with anti-IgM antibody (Jackson immunoresearch) and stained with either Mouse B Lymphocyte Activation Isotype Control (left panels) or Mouse B Lymphocyte Activation Antibody Cocktail (middle panels). Unactivated BALB/c splenocytes were stained with Mouse B Lymphocyte Activation Antibody Cocktail (right panels) or Mouse B Lymphocyte Activation Isotype Control (not shown). Scatter plots were used to select either activated lymphoblasts (left and middle panels) or resting lymphocytes (right panels) for data analysis. The two-color contour plots display the CD19+ B lymphocytes which express the activation antigens CD25 (top of middle and right panels) and CD69 (bottom of middle and right panels). Flow cytometry was performed on a BD FACSCalibur™ flow cytometry system.
Identification of activated B lymphocytes using Mouse B Lymphocyte Activation Antibody Cocktail, with Isotype Control. BALB/c splenocytes were activated by culture for 48 hours with anti-IgM antibody (Jackson immunoresearch) and stained with either Mouse B Lymphocyte Activation Isotype Control (left panels) or Mouse B Lymphocyte Activation Antibody Cocktail (middle panels). Unactivated BALB/c splenocytes were stained with Mouse B Lymphocyte Activation Antibody Cocktail (right panels) or Mouse B Lymphocyte Activation Isotype Control (not shown). Scatter plots were used to select either activated lymphoblasts (left and middle panels) or resting lymphocytes (right panels) for data analysis. The two-color contour plots display the CD19+ B lymphocytes which express the activation antigens CD25 (top of middle and right panels) and CD69 (bottom of middle and right panels). Flow cytometry was performed on a BD FACSCalibur™ flow cytometry system.
Identification of activated B lymphocytes using Mouse B Lymphocyte Activation Antibody Cocktail, with Isotype Control. BALB/c splenocytes were activated by culture for 48 hours with anti-IgM antibody (Jackson immunoresearch) and stained with either Mouse B Lymphocyte Activation Isotype Control (left panels) or Mouse B Lymphocyte Activation Antibody Cocktail (middle panels). Unactivated BALB/c splenocytes were stained with Mouse B Lymphocyte Activation Antibody Cocktail (right panels) or Mouse B Lymphocyte Activation Isotype Control (not shown). Scatter plots were used to select either activated lymphoblasts (left and middle panels) or resting lymphocytes (right panels) for data analysis. The two-color contour plots display the CD19+ B lymphocytes which express the activation antigens CD25 (top of middle and right panels) and CD69 (bottom of middle and right panels). Flow cytometry was performed on a BD FACSCalibur™ flow cytometry system.
Any use of products other than the permitted use without the express written authorization of Becton, Dickinson and Company is strictly prohibited.
The Mouse B Lymphocyte Activation Antibody Cocktail is a three-color reagent designed to identify major subsets of B lymphocytes by direct immunofluorescent staining with flow cytometric analysis. The PC61 antibody reacts with CD25, the low affinity IL-2 Receptor α chain (IL-2Rα, p55) expressed on activated T and B lymphocytes from all mouse strains tested. CD25 is also found on some developing B cells in the bone marrow, early developing T cells in the thymus, peripheral CD4+ regulatory T (Treg) cells, and dendritic cells. The H1.2F3 antibody reacts with CD69 (Very Early Activation antigen). Its expression is rapidly induced upon activation of lymphocytes (T, B, NK, and NK-T cells) neutrophils, and macrophages. CD69 is also expressed on thymocytes that are undergoing positive selection. The 1D3 antibody reacts with CD19, a B lymphocyte-lineage differentiation antigen that is expressed throughout B-lymphocyte development from the pro-B cell through the mature B-cell stages. Terminally differentiated plasma cells do not express CD19. The three antibodies have been titrated and pre-diluted, mixed together, and formulated for optimal staining performance. The Mouse B Lymphocyte Activation Isotype Control contains equivalent concentrations of fluorochrome- and isotype-matched negative-control immunoglobulin.
The use of three different fluorochromes for the labeling of the three different antibodies permits the recognition of each of the three antigens on each cell in a sample. The levels of expression of the three antigens distinguish the major subpopulations of developing and peripheral B lymphocytes. Additional fluorochrome-labeled reagents may be combined with the Mouse B Lymphocyte Activation Antibody Cocktail, and the Mouse B Lymphocyte Activation Isotype Control, to further characterize B-cell subpopulations.
| Description | Quantity/Size | Part Number |
|---|---|---|
| Mouse B Lymphocyte Activation Antibody Cocktail; PE-Cy™7 CD25, PE CD69, and FITC CD19 | 100 Tests (1 ea) | 51-9003395 |
| Mouse B Lymphocyte Activation Isotype Control; PE-Cy™7, PE, and FITC | 100 Tests (1 ea) | 51-9003396 |
Please refer to Support Documents for Quality Certificates
Global - Refer to manufacturer's instructions for use and related User Manuals and Technical data sheets before using this products as described
Comparisons, where applicable, are made against older BD Technology, manual methods or are general performance claims. Comparisons are not made against non-BD technologies, unless otherwise noted.
For Research Use Only. Not for use in diagnostic or therapeutic procedures.